Become a Member
  • Track your favourite stocks
  • Create & monitor portfolios
  • Daily portfolio value
Sign Up
Quickpicks
Add shares to your
quickpicks to
display them here!

ERGO.L (ERGO) Regulatory News

Date Source Headline
3rd Oct 2017 7:00 am RNS Completion of Acquisition of PSR Group BV
28th Sep 2017 10:46 am RNS Result of Placing
28th Sep 2017 7:02 am RNS Acquisition of PSR Group BV and Placing
27th Sep 2017 7:00 am RNS Commercialisation Deal on Haemostatix Products
18th Sep 2017 7:00 am RNS Interim Results
21st Aug 2017 7:06 am RNS CEL-SCI Corporation issues restricted shares
14th Aug 2017 12:31 pm RNS FDA removal of hold on Ph3 trial with Multikine
14th Aug 2017 7:00 am RNS Notice of Results
24th Jul 2017 7:00 am RNS Recruitment complete early for Phase IIb study
4th Jul 2017 12:30 pm RNS Investor Meeting
21st Jun 2017 7:00 am RNS PeproStat study passes recruitment mid-point
16th Jun 2017 5:44 pm RNS Result of AGM
16th Jun 2017 7:00 am RNS Appointment of CEO
22nd May 2017 7:00 am RNS Appointment of N+1 Singer as joint broker
12th May 2017 4:54 pm RNS Annual Report and Notice of AGM
8th May 2017 12:00 pm RNS Issue of Shares to Former PharmInvent Shareholders
2nd May 2017 7:00 am RNS Co-Development Partner News
13th Apr 2017 7:00 am RNS Board and Management Changes
4th Apr 2017 10:50 am RNS Director/PDMR Shareholding
3rd Apr 2017 7:00 am RNS Partner Asarina Pharma announces successful data
28th Mar 2017 7:00 am RNS Unaudited Preliminary Results for 2016
21st Mar 2017 7:00 am RNS Notice of Preliminary Results
20th Mar 2017 7:00 am RNS Initiates Phase II Study of Topical PeproStat
20th Feb 2017 7:00 am RNS Modus Therapeutics Raises SEK 32 Million
6th Feb 2017 7:02 am RNS Positive Phase II top-line results of Lorediplon
31st Jan 2017 4:00 pm RNS Completion of ZoptrexT Phase 3 Clinical Trial
17th Jan 2017 7:00 am RNS Trading Statement
30th Nov 2016 4:35 pm RNS Award of Options by CEO to CFO and General Counsel
29th Nov 2016 7:00 am RNS Acquisition of PharmInvent
21st Nov 2016 7:00 am RNS Proposed Board Changes
16th Nov 2016 7:00 am RNS Research Update from Modus Therapeutics
15th Nov 2016 4:33 pm RNS Holding(s) in Company
1st Nov 2016 7:00 am RNS Co-Development Agreement with Asarina AB
24th Oct 2016 7:00 am RNS Ergomed notes news from co-development partner
14th Oct 2016 7:00 am RNS Fourth licensing agreement for Zoptrex
26th Sep 2016 7:00 am RNS Half-year Report
22nd Sep 2016 7:00 am RNS Contract win validates rationale of acquisitions
16th Sep 2016 10:56 am RNS Ergomed receives a "buy" recommendation
8th Sep 2016 7:00 am RNS Recruitment completed in phase IIa clinical trial
7th Sep 2016 11:30 am RNS Notice of Results
FTSE 100 Latest
Value8,463.46
Change46.12